A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata

Alopecia areata (AA) is an autoimmune disorder of hair loss resulting from a T-cell mediated attack on hair follicles. Three Janus kinase (JAK) inhibitors have been approved for the treatment of moderate-to-severe alopecia areata; however, safety concerns for immunosuppressive therapy have limited t...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Robert Gensure, Brett King, Stephen Sikkink, Andrei Mardaryev, Robyn Goforth
Format:	Article
Language:	English
Published:	MDPI AG 2025-08-01
Subjects:	alopecia areata hair cycle stimulator JAK inhibitor BMD-1141
Online Access:	https://www.mdpi.com/2073-4409/14/16/1251